JP2005523284A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005523284A5 JP2005523284A5 JP2003569231A JP2003569231A JP2005523284A5 JP 2005523284 A5 JP2005523284 A5 JP 2005523284A5 JP 2003569231 A JP2003569231 A JP 2003569231A JP 2003569231 A JP2003569231 A JP 2003569231A JP 2005523284 A5 JP2005523284 A5 JP 2005523284A5
- Authority
- JP
- Japan
- Prior art keywords
- trypsin inhibitor
- amino acids
- essential amino
- kit
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101710162629 Trypsin inhibitor Proteins 0.000 claims 13
- 229940122618 Trypsin inhibitor Drugs 0.000 claims 13
- 239000002753 trypsin inhibitor Substances 0.000 claims 13
- 235000020776 essential amino acid Nutrition 0.000 claims 6
- 239000003797 essential amino acid Substances 0.000 claims 6
- 239000002552 dosage form Substances 0.000 claims 5
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 3
- 102000002322 Egg Proteins Human genes 0.000 claims 3
- 108010000912 Egg Proteins Proteins 0.000 claims 3
- 235000010469 Glycine max Nutrition 0.000 claims 3
- 244000068988 Glycine max Species 0.000 claims 3
- 235000014103 egg white Nutrition 0.000 claims 3
- 210000000969 egg white Anatomy 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 claims 2
- 108010039627 Aprotinin Proteins 0.000 claims 2
- 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 claims 2
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 claims 2
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 claims 2
- 229960004405 aprotinin Drugs 0.000 claims 2
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims 2
- 235000016709 nutrition Nutrition 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004142 Trypsin Human genes 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 229940024142 alpha 1-antitrypsin Drugs 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000035764 nutrition Effects 0.000 claims 1
- -1 trypsatin Proteins 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20020332A FI109970B (fi) | 2002-02-20 | 2002-02-20 | Valmiste ja menetelmä painon pudottamiseksi |
| PCT/FI2003/000107 WO2003070276A1 (en) | 2002-02-20 | 2003-02-12 | A preparation and method for weight reduction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005523284A JP2005523284A (ja) | 2005-08-04 |
| JP2005523284A5 true JP2005523284A5 (https=) | 2006-03-30 |
Family
ID=8563269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003569231A Pending JP2005523284A (ja) | 2002-02-20 | 2003-02-12 | 体重減少のための製剤およびその方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050096266A1 (https=) |
| EP (1) | EP1482976B1 (https=) |
| JP (1) | JP2005523284A (https=) |
| CN (1) | CN1729017A (https=) |
| AT (1) | ATE405290T1 (https=) |
| AU (1) | AU2003205795A1 (https=) |
| CA (1) | CA2476771A1 (https=) |
| DE (1) | DE60323062D1 (https=) |
| ES (1) | ES2314175T3 (https=) |
| FI (1) | FI109970B (https=) |
| WO (1) | WO2003070276A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080268038A1 (en) * | 2007-04-26 | 2008-10-30 | Wolfe Robert R | Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength |
| EP2067411A1 (en) * | 2007-11-29 | 2009-06-10 | Paolo Oddenino Paris S.R.L. | Food composition usable as substitute meal |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB652237A (en) * | 1945-12-27 | 1951-04-18 | Merck & Co Inc | Therapeutic amino acid mixtures |
| US4042687A (en) * | 1975-11-24 | 1977-08-16 | Control Drug, Inc. | Method of treating obesity by the oral administration of a predigested protein composition |
| US4491578A (en) * | 1982-06-14 | 1985-01-01 | Peikin Steven R | Method of stimulating satiety in mammals |
| JPH0623113B2 (ja) * | 1986-01-31 | 1994-03-30 | 浩 前田 | 癌性胸・腹水貯留抑制剤 |
| JPH02250823A (ja) * | 1989-03-24 | 1990-10-08 | Tsumura & Co | マイクロカプセル剤およびその製造方法 |
| FI920206A0 (fi) * | 1992-01-17 | 1992-01-17 | Pekka Untamo Heino | Medicinsk anvaendning, medicinskt foerfarande och preparat. |
| ES2087027B1 (es) * | 1994-08-03 | 1997-02-01 | Univ Illes Balears | Suplementos nutricionales termogeneticos, alimentos que los contienen y aplicaciones. |
| IT1320782B1 (it) * | 2000-07-04 | 2003-12-10 | Professional Dietetics Srl | Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca. |
| JP2002154976A (ja) * | 2000-11-22 | 2002-05-28 | Sanpo Kk | 慢性疾患の予防、改善及び／又は治療剤並びに健康食品 |
-
2002
- 2002-02-20 FI FI20020332A patent/FI109970B/fi active
-
2003
- 2003-02-12 CA CA002476771A patent/CA2476771A1/en not_active Abandoned
- 2003-02-12 DE DE60323062T patent/DE60323062D1/de not_active Expired - Fee Related
- 2003-02-12 WO PCT/FI2003/000107 patent/WO2003070276A1/en not_active Ceased
- 2003-02-12 ES ES03702672T patent/ES2314175T3/es not_active Expired - Lifetime
- 2003-02-12 AU AU2003205795A patent/AU2003205795A1/en not_active Abandoned
- 2003-02-12 AT AT03702672T patent/ATE405290T1/de not_active IP Right Cessation
- 2003-02-12 EP EP03702672A patent/EP1482976B1/en not_active Expired - Lifetime
- 2003-02-12 CN CNA038043793A patent/CN1729017A/zh active Pending
- 2003-02-12 JP JP2003569231A patent/JP2005523284A/ja active Pending
- 2003-02-12 US US10/504,148 patent/US20050096266A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Harnedy et al. | Purification and identification of dipeptidyl peptidase (DPP) IV inhibitory peptides from the macroalga Palmaria palmata | |
| Losso | The biochemical and functional food properties of the Bowman-Birk inhibitor | |
| Peñas et al. | Effects of combined high pressure and enzymatic treatments on the hydrolysis and immunoreactivity of dairy whey proteins | |
| JP2005501061A5 (https=) | ||
| JP2015509950A5 (https=) | ||
| ES2299253T3 (es) | Peptidos basados en la secuencia de la lactoferrina humana y sus usos,. | |
| ATE366317T1 (de) | Herstellung von peptiden und proteinen durch anhäufung in vom endoplasmatischen reticulum abgeleiteten proteinkörpern | |
| KR20110060940A (ko) | 항염증성 펩티드 | |
| EA200400664A1 (ru) | Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii | |
| RU2219925C2 (ru) | Аминокислотные композиции и их применение при иммунодепрессии | |
| WO2003008438A3 (fr) | Peptides et leur utilisation cosmetique ou dermatologique pour augmenter l'adhesion entre les cellules cutanees | |
| RU99103692A (ru) | Аминокислотные композиции и их применение при иммунодепрессии | |
| JP2005523284A5 (https=) | ||
| WO2004071156A3 (en) | Use of edible acid in fast-dispersing pharmaceutical solid dosage forms | |
| JP2005530703A5 (https=) | ||
| Gesinde et al. | Structural and functional characterization of legume seed ferritin concentrates | |
| DE69430416D1 (de) | Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen | |
| WO2005072056A3 (en) | Hsp therapy in conjunction with a low antigenicity diet | |
| Kim et al. | Characteristics of the protease inhibitor purified from chum salmon (Oncorhynchus keta) eggs | |
| ATE391510T1 (de) | Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii | |
| CA2368767A1 (en) | Protease resistant flint analogs | |
| KR20180102966A (ko) | 체내 흡수율 및 안정성이 우수한 벤포티아민을 함유하는 종합비타민 조성물 및 이의 제조방법 | |
| PT1289931E (pt) | Sais duplos de acido fumarico com uma carnitina e um aminoacido e suplementos alimentares, suplementos dieteticos e farmacos contendo os mesmos | |
| PL1916913T3 (pl) | Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko | |
| ATE405584T1 (de) | Arginin/lysin-angereicherte peptide |